---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-027854"
form_type: "8-K"
ticker: "DYAI"
cik: "0001213809"
company_name: "DYADIC INTERNATIONAL INC"
filed_at: "2023-10-06T23:59:59+00:00"
generated_at: "2026-06-10T03:15:04.145766+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Dyadic's collaboration with Janssen terminated; wind-down by Dec 31, 2023

## Summary
- Janssen Biotech provided written notice on Oct 2, 2023 to terminate the Research, License, and Collaboration Agreement with Dyadic.
- Collaboration effective end date is December 31, 2023.
- Agreement originally entered Dec 16, 2021 for manufacture of therapeutic proteins using Dyadic's C1 platform.

## SEC filing metadata
- accession: 0001437749-23-027854
- form_type: 8-K
- ticker: DYAI
- cik: 0001213809
- company_name: DYADIC INTERNATIONAL INC
- filed_at: 2023-10-06T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1213809/000143774923027854/0001437749-23-027854-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1213809/000143774923027854/dyai20231004c_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-027854
- JSON: https://secwatch.observer/filing/0001437749-23-027854.json
- Plain text: https://secwatch.observer/filing/0001437749-23-027854.txt

## Key facts
- Material Agreements
  DYADIC INTERNATIONAL INC terminated Research, License, and Collaboration Agreement with Janssen Biotech, Inc. (effective 2023-12-31).
  - Action: termination
  - Agreement: license
  - Counterparty: Janssen Biotech, Inc.
  - Effective: 2023-12-31
  source text: Pursuant to Section 12.3 of the Agreement, on October 2, 2023, Janssen provided written notice to Dyadic that it has decided to wind down the collaboration with an effective end date of December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1213809/000143774923027854/0001437749-23-027854-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.